JP2007509877A5 - ウチワサボテン植物の部分および／またはそれからの抽出物を含むうつ病治療剤 - Google Patents
ウチワサボテン植物の部分および／またはそれからの抽出物を含むうつ病治療剤 Download PDFInfo
- Publication number
- JP2007509877A5 JP2007509877A5 JP2006537161A JP2006537161A JP2007509877A5 JP 2007509877 A5 JP2007509877 A5 JP 2007509877A5 JP 2006537161 A JP2006537161 A JP 2006537161A JP 2006537161 A JP2006537161 A JP 2006537161A JP 2007509877 A5 JP2007509877 A5 JP 2007509877A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- agent according
- plant
- depression
- prickly pear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000001439 Opuntia Species 0.000 title claims 6
- 239000000284 extract Substances 0.000 title claims 5
- 239000003814 drug Substances 0.000 claims 8
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 6
- 241000196324 Embryophyta Species 0.000 claims 5
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 claims 3
- 229960002748 Norepinephrine Drugs 0.000 claims 3
- 229940076279 Serotonin Drugs 0.000 claims 3
- 239000000654 additive Substances 0.000 claims 3
- 230000001430 anti-depressive Effects 0.000 claims 3
- 239000000935 antidepressant agent Substances 0.000 claims 3
- 235000013389 devils tongue Nutrition 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 230000000144 pharmacologic effect Effects 0.000 claims 3
- 229940005513 ANTIDEPRESSANTS Drugs 0.000 claims 2
- 206010054089 Depressive symptom Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 201000008895 mood disease Diseases 0.000 claims 2
- 229960004688 venlafaxine Drugs 0.000 claims 2
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical group C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 claims 2
- 206010054196 Affect lability Diseases 0.000 claims 1
- 206010002855 Anxiety Diseases 0.000 claims 1
- 206010057666 Anxiety disease Diseases 0.000 claims 1
- 206010004939 Bipolar I disease Diseases 0.000 claims 1
- 206010004938 Bipolar disease Diseases 0.000 claims 1
- 206010024264 Lethargy Diseases 0.000 claims 1
- 206010025482 Malaise Diseases 0.000 claims 1
- 206010033666 Panic disease Diseases 0.000 claims 1
- 241001504519 Papio ursinus Species 0.000 claims 1
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 1
- 208000002094 Psychophysiologic Disorders Diseases 0.000 claims 1
- 206010054153 Somatoform disease Diseases 0.000 claims 1
- 230000000996 additive Effects 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000003001 depressive Effects 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 claims 1
- 238000002203 pretreatment Methods 0.000 claims 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 claims 1
- 230000036642 wellbeing Effects 0.000 claims 1
Claims (12)
- ウチワサボテン類、その植物の部分および／またはそれからの抽出物または生成物を含むことを特徴とする、抑うつ症状、うつ病あるいは抗うつ剤の影響を受けうるその他の情緒障害、およびこれらの病気の前段階の治療剤。
- 上記抗うつ剤の影響を受けうるその他の情緒障害が、不安症、パニック障害、双極性うつ病、心身症および月経前症候群から選ばれる障害である請求項１に記載の治療剤。
- 上記病気の前段階が、みじめ感、倦怠感、憂うつ感、無気力、情緒不安定、落胆感および幸福感の制約から選ばれる前段階である請求項１に記載の治療剤。
- 上記植物の部分が花および／または新芽若葉である請求項１乃至３のうちのいずれかの項に記載の治療剤。
- 上記ウチワサボテン類がオオガタホウケン種に属する請求項１乃至４のうちのいずれかの項に記載の治療剤。
- ウチワサボテン類またはその植物の部分からの抽出物を含む請求項１乃至５のうちのいずれかの項に記載の治療剤。
- 添加物として一種またはそれ以上の選択的セロトニンおよびノルアドレナリン再吸収阻害剤を含むことを特徴とする請求項１乃至６のうちのいずれかの項に記載の治療剤。
- 上記選択的セロトニンおよびノルアドレナリン再吸収阻害剤がベンラファキシンである請求項７に記載の治療剤。
- ウチワサボテン類、その植物の部分および／またはそれからの抽出物または生成物を含むことを特徴とする、抑うつ症状、うつ病あるいは抗うつ剤の影響を受けうるその他の情緒障害、およびこれらの病気の前段階の治療支援用食品。
- ウチワサボテン類、その植物の部分および／またはそれからの抽出物または生成物と、経口投与剤として適当な補薬とからなる薬理学的生成物。
- 添加物として一種またはそれ以上の選択的セロトニンおよびノルアドレナリン再吸収阻害剤を含むことを特徴とする請求項１０に記載の薬理学的生成物。
- 上記選択的セロトニンおよびノルアドレナリン再吸収阻害剤がベンラファキシンである請求項１１に記載の薬理学的生成物。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10350194.0 | 2003-10-28 | ||
| DE10350194A DE10350194B4 (de) | 2003-10-28 | 2003-10-28 | Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen |
| PCT/EP2004/012070 WO2005041994A1 (de) | 2003-10-28 | 2004-10-26 | Verwendung von feigenkaktus (opuntia) pflanzenteilen und/oder extrakten behandlung von depressionen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007509877A JP2007509877A (ja) | 2007-04-19 |
| JP2007509877A5 true JP2007509877A5 (ja) | 2007-12-13 |
| JP4863875B2 JP4863875B2 (ja) | 2012-01-25 |
Family
ID=34529823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006537161A Expired - Fee Related JP4863875B2 (ja) | 2003-10-28 | 2004-10-26 | ウチワサボテン植物の部分および／またはそれからの抽出物を含むうつ病治療剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070134355A1 (ja) |
| EP (1) | EP1682162B1 (ja) |
| JP (1) | JP4863875B2 (ja) |
| KR (1) | KR20070026329A (ja) |
| CN (1) | CN1867346B (ja) |
| AT (1) | ATE388719T1 (ja) |
| AU (1) | AU2004285274B2 (ja) |
| BR (1) | BRPI0415945A (ja) |
| CA (1) | CA2544050C (ja) |
| DE (2) | DE10350194B4 (ja) |
| ES (1) | ES2299878T3 (ja) |
| PL (1) | PL1682162T3 (ja) |
| PT (1) | PT1682162E (ja) |
| RU (1) | RU2336087C2 (ja) |
| UA (1) | UA82895C2 (ja) |
| WO (1) | WO2005041994A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2885524B1 (fr) * | 2005-05-10 | 2007-08-10 | Silab Sa | Procede d'obtention d'un actif cosmetique exfoliant, principe actif obtenu et compositions associees |
| WO2008038849A1 (en) * | 2006-09-29 | 2008-04-03 | Korea Institute Of Science And Technology | Pharmaceutical composition comprising an extract from opuntia ficus-indica |
| IL182284A0 (en) * | 2007-03-29 | 2008-01-20 | Avi Gal | A composition and method for inhibiting the enzyme 5 - alpha - reductase and the alpha - 1 - adrenergic receptor, treating related disorders, and a process for producing said composition |
| US7722904B2 (en) * | 2007-11-01 | 2010-05-25 | Access Business Group International Llc | Compositions and methods for stimulating synthesis of pro-collagen or collagen and hyaluronic acid |
| EP2057994A1 (de) | 2007-11-06 | 2009-05-13 | Finzelberg GmbH & Co. KG | Feigenkakteen-Extraktzubereitung |
| AT507988B1 (de) * | 2009-01-15 | 2012-06-15 | Kaahee Res And Dev Gmbh | Kaktusfruchtextrakt |
| US20100209557A1 (en) * | 2009-02-14 | 2010-08-19 | O'connor Daniel C | Recovery blends for liquid beverages |
| MX2012009288A (es) * | 2010-02-11 | 2013-01-24 | Schwabe Willmar Gmbh & Co | Uso de triglicosidos de isorhamnetina. |
| MA34856B1 (fr) * | 2012-07-09 | 2014-02-01 | Mariam Minhaj | Procédure d'obtenir une préparation à base des fleurs de cactus, et son utilisation |
| WO2020256243A1 (ko) * | 2019-06-17 | 2020-12-24 | 한국한의학연구원 | 부채마와 백년초의 혼합추출물을 포함하는 우울증 예방 또는 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9621486D0 (en) * | 1996-10-15 | 1996-12-04 | Isis Innovation | Oxygenase enzymes & method |
| UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
| GB9810092D0 (en) * | 1998-05-11 | 1998-07-08 | Merck Sharp & Dohme | Therapeutic agents |
| US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| MY124001A (en) * | 1999-04-23 | 2006-06-30 | E Excel Int | Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice |
| FR2823423B1 (fr) * | 2001-04-11 | 2004-08-27 | Bio Serae Laboratoires | Preparation a base de cactaceae ayant la propriete de fixer les graisses, et procede d'obtention d'une telle preparation |
| KR100523562B1 (ko) * | 2001-10-29 | 2005-10-25 | 한국과학기술연구원 | 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물 |
-
2003
- 2003-10-28 DE DE10350194A patent/DE10350194B4/de not_active Expired - Fee Related
-
2004
- 2004-10-26 US US10/577,624 patent/US20070134355A1/en not_active Abandoned
- 2004-10-26 UA UAA200603519A patent/UA82895C2/uk unknown
- 2004-10-26 AT AT04790853T patent/ATE388719T1/de active
- 2004-10-26 PL PL04790853T patent/PL1682162T3/pl unknown
- 2004-10-26 AU AU2004285274A patent/AU2004285274B2/en not_active Ceased
- 2004-10-26 WO PCT/EP2004/012070 patent/WO2005041994A1/de active IP Right Grant
- 2004-10-26 CA CA2544050A patent/CA2544050C/en not_active Expired - Fee Related
- 2004-10-26 DE DE502004006525T patent/DE502004006525D1/de active Active
- 2004-10-26 PT PT04790853T patent/PT1682162E/pt unknown
- 2004-10-26 RU RU2006117208/15A patent/RU2336087C2/ru not_active IP Right Cessation
- 2004-10-26 BR BRPI0415945-4A patent/BRPI0415945A/pt not_active IP Right Cessation
- 2004-10-26 ES ES04790853T patent/ES2299878T3/es active Active
- 2004-10-26 EP EP04790853A patent/EP1682162B1/de not_active Not-in-force
- 2004-10-26 KR KR1020067008209A patent/KR20070026329A/ko not_active Application Discontinuation
- 2004-10-26 CN CN2004800304073A patent/CN1867346B/zh not_active Expired - Fee Related
- 2004-10-26 JP JP2006537161A patent/JP4863875B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509877A5 (ja) | ウチワサボテン植物の部分および／またはそれからの抽出物を含むうつ病治療剤 | |
| Lieberman | History of the use of antidepressants in primary care | |
| Öztürk et al. | The Anti-Inflammatory Activity of Eugenia caryophllata Essential Oil: An animal model of anti-inflammatory activity | |
| Perveen et al. | Increased 5-HT levels following repeated administration of Nigella sativa L.(black seed) oil produce antidepressant effects in rats | |
| Tong et al. | Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves | |
| ATE401872T1 (de) | Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels | |
| CY1108287T1 (el) | Χρηση του εναντιομερους (1s, 2r) της μιλνακιπρανης για την παρασκευη ενος φαρμακου | |
| Pandi-Perumal et al. | Could agomelatine be the ideal antidepressant? | |
| Paula‐Freire et al. | Evaluation of the antinociceptive activity of Ocimum gratissimum L.(Lamiaceae) essential oil and its isolated active principles in mice | |
| Ghasemi et al. | NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test | |
| DE502005008790D1 (de) | Substituierte phenylaminopyrimidine | |
| ECSP055885A (es) | Derivados de carbostirilo e inhibidores de la recaptacion de serotonina que sirven para el tratamiento de desordenes en el humor | |
| Davidson et al. | The potential utility of some legal highs in CNS disorders | |
| Ishola et al. | Antidepressant-like effect of the hydroethanolic leaf extract of Alchornea cordifolia (Schumach. & Thonn.) Mull. Arg.(Euphorbiaceae) in mice: Involvement of monoaminergic system | |
| Zhang et al. | Cang-Ai volatile oil ameliorates depressive behavior induced by chronic stress through IDO-mediated tryptophan degradation pathway | |
| Zakaria et al. | The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of l‐arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice | |
| RU2006117208A (ru) | Применение частей опунции и/или экстрактов из нее для лечения депрессий | |
| AR045423A1 (es) | Combinaciones de analiticos y antidepresivos | |
| Bantug et al. | The burgeoning world of immunometabolites: Th17 cells take center stage | |
| JP2007505156A5 (ja) | ||
| CN102119956A (zh) | 降香油在制备抗人体病原菌药物中应用和降香香水 | |
| CN107375607A (zh) | 一种治疗抑郁症的药物 | |
| Taher et al. | CNS depressant activity of Chamomile methanol extract in mice | |
| Xie et al. | Structure-activity relationship of 39 analogs of laetispicine with antidepressant properties | |
| Essien et al. | Anti-inflammatory and anti-nociceptive potentials of Salacia lehmbachii leaves |